These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37486571)

  • 1. Addressing PTSD in Implantable Cardioverter Defibrillator Patients: State-of-the-Art Management of ICD Shock and PTSD.
    F SS; R H; A S; E J; S A; Z H; R N
    Curr Cardiol Rep; 2023 Sep; 25(9):1029-1039. PubMed ID: 37486571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.
    Ladwig KH; Baumert J; Marten-Mittag B; Kolb C; Zrenner B; Schmitt C
    Arch Gen Psychiatry; 2008 Nov; 65(11):1324-30. PubMed ID: 18981344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable Cardioverter Defibrillator Shocks and Psychological Distress: Examining the Mediating Roles of Implantable Cardioverter Defibrillator-Related Concerns and Perceived Control.
    Lee KS; Hammash MH; Kim JH; Kang KW; Miller J; McEvedy SM; Hwang SY; Moser DK
    J Cardiovasc Nurs; 2020; 35(1):66-73. PubMed ID: 31441803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease.
    Ingles J; Sarina T; Kasparian N; Semsarian C
    Int J Cardiol; 2013 Oct; 168(4):3779-84. PubMed ID: 23835269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of implantable cardioverter defibrillator shocks during the first year.
    Dougherty CM; Hunziker J
    J Cardiovasc Nurs; 2009; 24(1):21-8; quiz 29-30. PubMed ID: 19114797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical function, psychological adjustment, and self-efficacy following sudden cardiac arrest and an initial implantable cardioverter defibrillator (ICD) in a social cognitive theory intervention: secondary analysis of a randomized control trial.
    Dougherty CM; Liberato ACS; Streur MM; Burr RL; Kwan KY; Zheng T; Auld JP; Thompson EA
    BMC Cardiovasc Disord; 2022 Aug; 22(1):369. PubMed ID: 35948889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and predictors of implantable cardioverter-defibrillator therapy and its complications in idiopathic ventricular fibrillation patients.
    Blom LJ; Visser M; Christiaans I; Scholten MF; Bootsma M; van den Berg MP; Yap SC; van der Heijden JF; Doevendans PA; Loh P; Postema PG; Barge-Schaapsveld DQ; Hofman N; Volders PGA; Wilde AA; Hassink RJ
    Europace; 2019 Oct; 21(10):1519-1526. PubMed ID: 31114860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sudden cardiac death in the youth. Is the new subcutaneous implantable cardioverter defibrillator S-ICD an alternative solution?].
    Roche NC; Stefuriac M; Dumitrescu N; Charbonnel A; Godreuil C; Bonnevie L
    Ann Cardiol Angeiol (Paris); 2015 Feb; 64(1):27-31. PubMed ID: 25281995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of mood symptoms and disorders in implantable cardioverter defibrillator patients: a systematic review and meta-analysis of 39 954 patients.
    Ghezzi ES; Sharman RLS; Selvanayagam JB; Psaltis PJ; Sanders P; Astley JM; Knayfati S; Batra V; Keage HAD
    Europace; 2023 Jun; 25(6):. PubMed ID: 37311667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillator shocks: epidemiology, outcomes, and therapeutic approaches.
    Borne RT; Varosy PD; Masoudi FA
    JAMA Intern Med; 2013 May; 173(10):859-65. PubMed ID: 23546173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceived support from healthcare professionals, shock anxiety and post-traumatic stress in implantable cardioverter defibrillator recipients.
    Morken IM; Bru E; Norekvål TM; Larsen AI; Idsoe T; Karlsen B
    J Clin Nurs; 2014 Feb; 23(3-4):450-60. PubMed ID: 24102743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive-Behavioral Treatment of Posttraumatic Stress in Patients With Implantable Cardioverter Defibrillators: Results From a Randomized Controlled Trial.
    Ford J; Rosman L; Wuensch K; Irvine J; Sears SF
    J Trauma Stress; 2016 Aug; 29(4):388-92. PubMed ID: 27415850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy-Are there predictors of appropriate therapy?
    Weissler-Snir A; Dorian P; Rakowski H; Care M; Spears D
    Heart Rhythm; 2021 Jan; 18(1):63-70. PubMed ID: 32800967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding implantable cardioverter defibrillator shocks and storms: medical and psychosocial considerations for research and clinical care.
    Sears SE; Conti JB
    Clin Cardiol; 2003 Mar; 26(3):107-11. PubMed ID: 12685615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD).
    Cheng A; Zhang Y; Blasco-Colmenares E; Dalal D; Butcher B; Norgard S; Eldadah Z; Ellenbogen KA; Dickfeld T; Spragg DD; Marine JE; Guallar E; Tomaselli GF
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1084-91. PubMed ID: 25273351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttraumatic stress disorder in pediatric patients with implantable cardioverter-defibrillators and their parents.
    Schneider LM; Wong JJ; Adams R; Bates B; Chen S; Ceresnak SR; Danovsky M; Hanisch D; Motonaga KS; Restrepo M; Shaw RJ; Sears SF; Trela A; Dubin AM; Hood KK
    Heart Rhythm; 2022 Sep; 19(9):1524-1529. PubMed ID: 35772698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness evaluation.
    Healy CA; Carrillo RG
    Heart Rhythm; 2015 Jul; 12(7):1565-73. PubMed ID: 25839113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttraumatic stress and anxiety in patients with an implantable cardioverter defibrillator: Trajectories and vulnerability factors.
    Habibović M; Denollet J; Pedersen SS;
    Pacing Clin Electrophysiol; 2017 Jul; 40(7):817-823. PubMed ID: 28432794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defibrillator shocks and their effect on objective and subjective patient outcomes: Results of the PainFree SST clinical trial.
    Sears SF; Rosman L; Sasaki S; Kondo Y; Sterns LD; Schloss EJ; Kurita T; Meijer A; Raijmakers J; Gerritse B; Auricchio A
    Heart Rhythm; 2018 May; 15(5):734-740. PubMed ID: 29277687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.